Evidence map›Paper›PMID 38760336›Full record

ArticleNature communications2024

Para-selective nitrobenzene amination lead by C(sp

Zhen Zhang, Shusheng Yue, Bo Jin, Ruchun Yang, Shengchun Wang, Tianqi Zhang, Li Sun, Aiwen Lei, Hu Cai

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhen Zhang *School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, Jiangxi, People's Republic of China. zhangzhen@ncu.edu.cn.ORCID http://orcid.org/0000-0003-0480-5001
Shusheng Yue *School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, Jiangxi, People's Republic of China.
Bo JinSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, Jiangxi, People's Republic of China.
Ruchun YangSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, Jiangxi, People's Republic of China.
Shengchun WangCollege of Chemistry and Molecular Sciences, Wuhan University, Wuhan, Hubei, People's Republic of China.ORCID http://orcid.org/0000-0003-3038-3404
Tianqi ZhangSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, Jiangxi, People's Republic of China.
Li SunSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, Jiangxi, People's Republic of China.
Aiwen LeiSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, Jiangxi, People's Republic of China. aiwenlei@whu.edu.cn.ORCID http://orcid.org/0000-0001-8417-3061
Hu CaiSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, Jiangxi, People's Republic of China. caihu@ncu.edu.cn.ORCID http://orcid.org/0000-0003-2372-3319

Funding

National Natural Science Foundation of China (National Science Foundation of China) 21861026National Natural Science Foundation of China (National Science Foundation of China) 22075123
6 · The paper itself

Abstract

Arylamines, serving as crucial building blocks in natural products and finding applications in multifunctional materials, are synthesized on a large scale via an electrophilic nitration/reduction sequence. However, the current methods for aromatic C-H amination have not yet attained the same level of versatility as electrophilic nitration. Here we show an extensively investigated transition metal-free and regioselective strategy for the amination of nitrobenzenes, enabling the synthesis of 4-nitro-N-arylamines through C(sp

Identifiers

PMID38760336
PMCPMC11101647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.